T. Rowe Price Associates’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,909,257
| Closed | -$97M | – | 3099 |
|
|
2024
Q3 | $97M | Buy |
2,909,257
+400,721
| +16% | +$13.4M | 0.01% | 571 |
|
|
2024
Q2 | $67.8M | Buy |
2,508,536
+290,541
| +13% | +$7.85M | 0.01% | 625 |
|
|
2024
Q1 | $47.9M | Buy |
2,217,995
+591,013
| +36% | +$12.8M | 0.01% | 736 |
|
|
2023
Q4 | $9.81M | Sell |
1,626,982
-145,366
| -8% | -$877K | ﹤0.01% | 1098 |
|
|
2023
Q3 | $9.86M | Buy |
1,772,348
+81,018
| +5% | +$450K | ﹤0.01% | 1071 |
|
|
2023
Q2 | $12.4M | Buy |
1,691,330
+226,556
| +15% | +$1.66M | ﹤0.01% | 1033 |
|
|
2023
Q1 | $5.76M | Sell |
1,464,774
-46,187
| -3% | -$182K | ﹤0.01% | 1152 |
|
|
2022
Q4 | $4.78M | Buy |
1,510,961
+1,186
| +0.1% | +$3.75K | ﹤0.01% | 1199 |
|
|
2022
Q3 | $5.62M | Sell |
1,509,775
-1,964
| -0.1% | -$7.31K | ﹤0.01% | 1176 |
|
|
2022
Q2 | $4.67M | Sell |
1,511,739
-500
| -0% | -$1.55K | ﹤0.01% | 1428 |
|
|
2022
Q1 | $7.85M | Sell |
1,512,239
-512,377
| -25% | -$2.66M | ﹤0.01% | 1401 |
|
|
2021
Q4 | $9.8M | Sell |
2,024,616
-260,674
| -11% | -$1.26M | ﹤0.01% | 1408 |
|
|
2021
Q3 | $20.4M | Sell |
2,285,290
-1,999
| -0.1% | -$17.8K | ﹤0.01% | 1289 |
|
|
2021
Q2 | $20.1M | Sell |
2,287,289
-15,460
| -0.7% | -$136K | ﹤0.01% | 1297 |
|
|
2021
Q1 | $36.2M | Buy |
+2,302,749
| New | +$36.2M | ﹤0.01% | 1114 |
|